SI7812162A8 - Process for determining alpha-amilase - Google Patents
Process for determining alpha-amilase Download PDFInfo
- Publication number
- SI7812162A8 SI7812162A8 SI7812162A SI7812162A SI7812162A8 SI 7812162 A8 SI7812162 A8 SI 7812162A8 SI 7812162 A SI7812162 A SI 7812162A SI 7812162 A SI7812162 A SI 7812162A SI 7812162 A8 SI7812162 A8 SI 7812162A8
- Authority
- SI
- Slovenia
- Prior art keywords
- glucose
- amylase
- process according
- determined
- glucosidase
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 47
- 230000008569 process Effects 0.000 title claims description 22
- 239000000758 substrate Substances 0.000 claims description 26
- 239000004382 Amylase Substances 0.000 claims description 25
- 238000003776 cleavage reaction Methods 0.000 claims description 23
- 230000007017 scission Effects 0.000 claims description 23
- 102000013142 Amylases Human genes 0.000 claims description 19
- 108010065511 Amylases Proteins 0.000 claims description 19
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 19
- 235000019418 amylase Nutrition 0.000 claims description 19
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 17
- 150000001875 compounds Chemical class 0.000 claims description 13
- 241000269821 Scombridae Species 0.000 claims description 12
- 235000020640 mackerel Nutrition 0.000 claims description 12
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 11
- 102100031126 6-phosphogluconolactonase Human genes 0.000 claims description 10
- 108010029731 6-phosphogluconolactonase Proteins 0.000 claims description 10
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 claims description 10
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 10
- -1 ROH compound Chemical class 0.000 claims description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 8
- 108010057899 Maltose phosphorylase Proteins 0.000 claims description 8
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 7
- 239000000174 gluconic acid Substances 0.000 claims description 7
- 235000012208 gluconic acid Nutrition 0.000 claims description 7
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims description 6
- 108010021382 Gluconokinase Proteins 0.000 claims description 5
- 102100024009 Probable gluconokinase Human genes 0.000 claims description 5
- 230000002255 enzymatic effect Effects 0.000 claims description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 claims description 4
- 101710088194 Dehydrogenase Proteins 0.000 claims description 4
- NEZJDVYDSZTRFS-RMPHRYRLSA-N Phenyl beta-D-glucopyranoside Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1 NEZJDVYDSZTRFS-RMPHRYRLSA-N 0.000 claims description 4
- HXXFSFRBOHSIMQ-VFUOTHLCSA-N alpha-D-glucose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-VFUOTHLCSA-N 0.000 claims description 4
- 229950010772 glucose-1-phosphate Drugs 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- BIRSGZKFKXLSJQ-SQOUGZDYSA-N 6-Phospho-D-gluconate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O BIRSGZKFKXLSJQ-SQOUGZDYSA-N 0.000 claims description 3
- 108091006149 Electron carriers Proteins 0.000 claims description 3
- 101000935015 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) N-acetyl-6-hydroxytryptophan oxidase ivoB Proteins 0.000 claims description 3
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 claims description 3
- 102000006995 beta-Glucosidase Human genes 0.000 claims description 3
- 108010047754 beta-Glucosidase Proteins 0.000 claims description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 claims description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 235000000346 sugar Nutrition 0.000 claims description 3
- 108010078791 Carrier Proteins Proteins 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 150000008131 glucosides Chemical group 0.000 claims description 2
- 230000009467 reduction Effects 0.000 claims description 2
- 108010009384 L-Iditol 2-Dehydrogenase Proteins 0.000 claims 1
- 102000009569 Phosphoglucomutase Human genes 0.000 claims 1
- 102100026974 Sorbitol dehydrogenase Human genes 0.000 claims 1
- 108091000115 phosphomannomutase Proteins 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 description 32
- 108010028144 alpha-Glucosidases Proteins 0.000 description 28
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 27
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 27
- 102000004139 alpha-Amylases Human genes 0.000 description 24
- 108090000637 alpha-Amylases Proteins 0.000 description 24
- 229940024171 alpha-amylase Drugs 0.000 description 24
- 239000000047 product Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
- 239000008103 glucose Substances 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 239000000872 buffer Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000011780 sodium chloride Substances 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000008363 phosphate buffer Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 102000005548 Hexokinase Human genes 0.000 description 9
- 108700040460 Hexokinases Proteins 0.000 description 9
- 229920002472 Starch Polymers 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 235000019698 starch Nutrition 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 8
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 8
- 241000178960 Paenibacillus macerans Species 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 7
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 7
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 7
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 229920001542 oligosaccharide Polymers 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 5
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 230000008033 biological extinction Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 5
- 150000002482 oligosaccharides Polymers 0.000 description 5
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 5
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 4
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 4
- JORABGDXCIBAFL-UHFFFAOYSA-M iodonitrotetrazolium chloride Chemical compound [Cl-].C1=CC([N+](=O)[O-])=CC=C1N1[N+](C=2C=CC(I)=CC=2)=NC(C=2C=CC=CC=2)=N1 JORABGDXCIBAFL-UHFFFAOYSA-M 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 125000003831 tetrazolyl group Chemical group 0.000 description 4
- 108020001657 6-phosphogluconate dehydrogenase Proteins 0.000 description 3
- 102000004567 6-phosphogluconate dehydrogenase Human genes 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- RWHOZGRAXYWRNX-VFUOTHLCSA-N alpha-D-glucose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H](OP(O)(O)=O)[C@@H]1O RWHOZGRAXYWRNX-VFUOTHLCSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000011533 pre-incubation Methods 0.000 description 3
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- BTJIUGUIPKRLHP-UHFFFAOYSA-M 4-nitrophenolate Chemical compound [O-]C1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-M 0.000 description 2
- 101710125031 6-phosphogluconate dehydrogenase, NAD(+)-dependent, decarboxylating Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108090001003 Beta-phosphoglucomutases Proteins 0.000 description 2
- 101100459440 Caenorhabditis elegans nac-3 gene Proteins 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 239000001116 FEMA 4028 Substances 0.000 description 2
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108010008488 Glycylglycine Proteins 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 229960004853 betadex Drugs 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000004992 fission Effects 0.000 description 2
- 125000003147 glycosyl group Chemical group 0.000 description 2
- 229940043257 glycylglycine Drugs 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002803 maceration Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000001044 red dye Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- MHKBMNACOMRIAW-UHFFFAOYSA-N 2,3-dinitrophenol Chemical class OC1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O MHKBMNACOMRIAW-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- WFPZSXYXPSUOPY-ROYWQJLOSA-N ADP alpha-D-glucoside Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WFPZSXYXPSUOPY-ROYWQJLOSA-N 0.000 description 1
- WFPZSXYXPSUOPY-UHFFFAOYSA-N ADP-mannose Natural products C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COP(O)(=O)OP(O)(=O)OC1OC(CO)C(O)C(O)C1O WFPZSXYXPSUOPY-UHFFFAOYSA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- FNZLKVNUWIIPSJ-UHNVWZDZSA-N D-ribulose 5-phosphate Chemical compound OCC(=O)[C@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHNVWZDZSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101001047085 Homo sapiens Kielin/chordin-like protein Proteins 0.000 description 1
- 102100022808 Kielin/chordin-like protein Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000051584 NAD kinases Human genes 0.000 description 1
- 108010084634 NADP phosphatase Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- FNZLKVNUWIIPSJ-UHFFFAOYSA-N Rbl5P Natural products OCC(=O)C(O)C(O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHFFFAOYSA-N 0.000 description 1
- 101100311330 Schizosaccharomyces pombe (strain 972 / ATCC 24843) uap56 gene Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 101001047124 Xenopus laevis Kielin/chordin-like protein Proteins 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- OCIBBXPLUVYKCH-QXVNYKTNSA-N alpha-maltohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-QXVNYKTNSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- BQDSDRAVKYTTTH-UHFFFAOYSA-N barium(2+);methanolate Chemical compound [Ba+2].[O-]C.[O-]C BQDSDRAVKYTTTH-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- MOOAHMCRPCTRLV-UHFFFAOYSA-N boron sodium Chemical compound [B].[Na] MOOAHMCRPCTRLV-UHFFFAOYSA-N 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ZIWYFFIJXBGVMZ-UHFFFAOYSA-N dioxotin hydrate Chemical compound O.O=[Sn]=O ZIWYFFIJXBGVMZ-UHFFFAOYSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 125000004395 glucoside group Chemical group 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- DJMVHSOAUQHPSN-UHFFFAOYSA-N malto-hexaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(O)C(CO)O4)O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 DJMVHSOAUQHPSN-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- RBXVOQPAMPBADW-UHFFFAOYSA-N nitrous acid;phenol Chemical class ON=O.OC1=CC=CC=C1 RBXVOQPAMPBADW-UHFFFAOYSA-N 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000012434 nucleophilic reagent Substances 0.000 description 1
- 125000001209 o-nitrophenyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])[N+]([O-])=O 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004801 process automation Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000012262 resinous product Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 101150018444 sub2 gene Proteins 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
Tehnični problemA technical problem
Obstajala je potreba po ugotovitvi novega, tehnološko naprednega postopka za določitev «/--amilaze v raztopini kot telesni tekočini izven človeškega ali živalskega telesa, z encimatsko cepitvijo substrata d—amilaze, ob ugodnih vrednostih lag-faze in dosegljive maksimalne aktivnosti, brez dragih in kompliciranih aparatur in možni avtomatizaciji za industrijsko izvedbo postopka.There was a need to find a new, technologically advanced process for the determination of «/ - amylase in solution as a body fluid outside the human or animal body, with enzymatic cleavage of the d-amylase substrate, at favorable lag-phase values and achievable maximum activity, without expensive and complicated apparatus and possible automation for industrial process execution.
Stanje tehnikeThe state of the art
Določitev koncentracije α-amilaze v serumu je važen klinični parameter za funkcijo trebušne slinavke. Običajni tržni reagenti za določitev α-amilaze so osnovani. pretežno na sistemu, pri katerem α-amilaza razgradi škrob in nastale razgrajene delce določijo v vidnem ali UV območju, v odvisnosti od tega, ali uporabijo v testuDetermination of serum α-amylase concentration is an important clinical parameter for pancreatic function. Conventional commercial reagents for the determination of α-amylase are warranted. predominantly on a system in which α-amylase degrades starch and the resulting degraded particles are determined in the visible or UV range, depending on whether they are used in the assay
- 2 kot substrat za amilazo obarvani škrob ali nativni škrob. Bistvena hiba teh postopkov oz. reagentov je v tem, da škro ba kot makromolekule ni mogoče zadostno karakterizirati in standardizirati, tako, da kažejo posamezne šarže zelo različno stopnjo presnove in je treba pri merjenjih vedno delati istočasno še s standardom. Za boljše rezultate bi bil potreben enotnejši substrat, ki daje pri cepitvi zanesljive rezultate.- 2 as starch for amylase colored starch or native starch. The essential flaw in these procedures or. of the reagents is that the starch as a macromolecule cannot be sufficiently characterized and standardized so that the individual batches exhibit very different levels of metabolism and must always be operated at the same time as standard for measurements. Better results would require a more uniform substrate that gives reliable fission results.
Korak naprej V smeri enotnejšega substrata je pomenila uporaba maltopentaoze. α-aailaza jo cepi v maltotriozo in maltozo, maltotriozo in maltozo prevedejo z aglukozidazo v glukozo, ki jo lahko potem določijo po poljubnih metodah, npr. z znano heksokinazno metodo.A step forward In the direction of a more uniform substrate, the use of maltopentasis was implied. α-aailase cleaves it into maltotriose and maltose, maltotriose and maltose are converted by glucose to glucose, which can then be determined by any method, e.g. by the known hexokinase method.
Poleg maltopentaoze so kot substrat predlagali že tudi maltotetraozo in maltoheksaozo (patenta ZDA . 4In addition to maltopentasis, maltotetraose and maltohexaose have been proposed as a substrate (US patent 4.
879 265, * 000 042). Vendar so pri tem s tetraozo dosegli izrazito slabše rezultate kot s pentaozo, in s heksaozo še slabše rezultate kot s tetraozo. Tako navajajo za maltotetraozo in -pentaozo še stehiometrično reakcijo, medtem ko ugotavljajo za heksaozo odstopanja od stehiometricne reakcije, ki jih je komaj Še možno tolerirati.879 265, * 000 042). However, tetraose achieved significantly worse results than pentase and hexaose worse than tetraose. Thus, the stochiometric reaction is also referred to as maltotetraose and -pentase, while the deviations from the stoichiometric reaction, which can hardly be tolerated, are found for hexaose.
Hiba maltopentaoze, ki smo jo ugotovili tudi pri tetraozi, pa je, da se pojavi znatna prazna vrednost reagentov, t.j., da meritvena reakcija že teče, še predno je dodan skusek, ki ga je treba določiti. Razen tega pa tudi ta prazna vrednost reagentov pri višjih koncentracijah substrata ni konstantna, temveč se več kot 25 minut spreminja, preden je dosežena konstantnost te stranske reakcije. Pokazalo se je tudi, da domnevne različne cepitve maltopentaoze s pankreas-a-amilazo in saliva-a-amilazo, ki bi omogočilo razlikovanje, dejansko sploh ni (J. BC, 1970, 24^,3917 do 3927; J. Biochem. 21» P· XVIH 1952)e Opis rešitve tehničnega problema z izvedbenimi primeriThe drawback of maltopentasis, which was also found in tetraosis, is that a significant blank value of reagents appears, ie that the measurement reaction is already underway, before the experiment to be determined is added. In addition, this blank value of reagents is not constant at higher substrate concentrations, but changes more than 25 minutes before the constancy of this side reaction is reached. It has also been shown that there are, in fact, no presumed different cleavages of pancreatic-a-amylase and saliva-a-amylase by maltopentasis, which actually do not exist at all (J. BC, 1970, 24 ^, 3917 to 3927; J. Biochem. 21 »P · XVIH 1 952) e Description of the solution of a technical problem with implementation examples
Naloga izuma je torej ustvariti nov, tehnološki postopek za določitev cC-amilaze, pri katerem uporabimo substrat, ki kaže boljšo Čistoto in enotnost kot znani substrati, ki je lahko dostopen in glede prazne vrednosti brez seruma, trajanja lag-faze in dosegljive maksimalne aktivnosti ustreza zahtevam. Razen tega naj bi bila mogoča preprosta meritev brez dragih in kompliciranih aparatur in primernost za hitre diagnostike, kot testne trakove za avtomatizacijo postopka.The object of the invention is therefore to create a novel, technological process for the determination of cC-amylase, using a substrate that exhibits better Purity and Unity than known substrates, which is readily available and, with respect to serum free value, lag phase duration and achievable maximum activity, corresponds to I demand. In addition, simple measurement without expensive and complicated apparatus and suitability for rapid diagnostics such as test strips for process automation should be possible.
V smislu izuma rešimo to nalogo z navim postopkom za določitev &—amilaze z encimatsko cepitvijo substrataAccording to the invention, this task is solved by a threaded process for the determination of & - amylase by enzymatic cleavage of a substrate
-amilaze in meritvijo proizvoda cepitve, pri katerem raztopino skuska presnovimo z °t--glukozidazo in spojino s splošno formulo I-amylase and measurement of the cleavage product in which the mackerel solution is reacted with ° t - glucosidase and a compound of general formula I
ff
- 4 v kateri predstavlja R glukozidno, fenilglukozidno, mononitrofenilglukozidno, dinitrofenilglukozidno, sorbitno skupino ali skupino glukonske kisline.- 4 in which R represents a glucosidic, phenylglucoside, mononitrophenylglucoside, dinitrophenylglucoside, sorbitol or gluconic acid group.
Presenetljivo se je pokazalo, da ima maltoheptaoza kot substrat α-amilaze boljše lastnosti, četudi so pri oligomaltozah, ki so bile za ta namen že predlagane , od mal topentaoze proti maltoheksaozi ugotovili bistveno upadanje primernosti, ker dosežejo z njo bistveno slabše rezultate kot s pentaozo· Zato je bilo pričakovati, da bodo z nadaljnjim podaljšanjem oligosaharidne verige maltoze nastopile napake, ki jih ne bo več mogoče tolerirati. Presenetljivo pa smo dosegli boljše rezultate kot s pentaozo. Tako znaša prazna vrednost reagentov pri 0,02 ml skusku z maltopentaozo kot substratom 75 %, z maltobeptaozo pa le 15 %, računano na končno vrednost določitve v normalnem območju.Surprisingly, maltoheptasis as an α-amylase substrate has been shown to have better properties, even though oligomaltoses already proposed for this purpose have shown a significant decrease in fitness from mal topentasis to maltohexosis, since they achieve significantly worse results than with pentaoza. · Therefore, it was expected that further extensions of the maltose oligosaccharide chain would cause errors that would no longer be tolerated. Surprisingly, however, we achieved better results than with pentase. Thus, the blank value of the reagents in 0.02 ml mackerel with the substrate was 75%, and with maltobeptasis only 15%, calculated on the final determination value in the normal range.
Razen tega smo ugotovili, da lahko namesto maltoheptaoze same uporabimo tudi določene derivate maltoheptaoze, ki tvorijo pri učinkovanju α-amilaze derivatiziran proizvod cepitve, ki se ga da določiti posebno ugodno.In addition, we have found that, instead of maltoheptasis, we can also use certain derivatives of maltoheptasis which, in the action of α-amylase, produce a derivatized cleavage product that can be determined to be particularly advantageous.
Postopek v smislu izuma je primeren zlasti za določitev proizvodov cepitve z α-glukozidazo ali maltozefosforilazo.The process of the invention is particularly suitable for determining the cleavage products of α-glucosidase or maltosephosphorylase.
Pri določitvi z α-glukozidazo in spojine s splošno formulo I, v kateri je R glukozid, se proizvodi cepitve maltoheptaoze, maltotetraoze in maltotrioze daljeDetermination by α-glucosidase and compounds of general formula I in which R is a glucoside produces the cleavage of maltoheptasis, maltotetraose and maltotriose
- 5 cepijo v glukozo, slednjo pa potem na znan način merimo.- 5 are vaccinated in glucose, and the latter is then measured in a known manner.
Za merjenje nastale glukoze dajemo pri tem v prisotnosti α-glukozidaze prednost zlasti heksokinaznemu postopku. Princip te izvedbene oblike postopka v smislu izuma lahko podamo z naslednjimi enačbami:In the presence of α-glucosidase, the hexokinase process is particularly preferred for the measurement of glucose produced. The principle of this embodiment of the process of the invention can be given by the following equations:
maltoheptaoza + HpO ffam^3-aza> maltotrioza + maltote* traoza maltotrioza + 2HpO g-glukozidaža > 5 glukoze maltotetraoza + 3HpO a~glukozidaza 4 glukoze glukoz + 7 ATP 7 glukoze- 6-P glukoze-6-Ρ + 7NAD+ G 6 FDH > 7 glukonat-6-P+7NADH + 7H+ maltoheptasis + HpO f am ^ 3 - aza > maltotriose + maltose * trause maltotriose + 2HpO g-glucosidase> 5 glucose maltotetraose + 3HpO a ~ g lucosidase 4 glucose glucose + 7 ATP 7 glucose-6-P glucose-6-Ρ + 7N + G 6 FDH > 7 gluconate-6-P + 7NADH + 7H +
Za to izvedbeno obliko izuma so zlasti primerni tudi v smislu izuma uporabljeni derivati maltoheptaoze, to rej spojine s splošno formulo I, v kateri R ne predstavlja glukozidne skupine. Pri učinkovanju obeh encimov, a-amilaze in α-glukozidaze, se substituent, torej fenilna skupina, mononitrofenilna skupina ali dinitrofenilna skupina oz. končni ostanek sorbita ali glukoneke kisline odcepi in ga zlahka določimo. Fenilne skupine lahko stoje v a- ali βlegi. če gre za α-lego, se vrši njihova odcepitev z učin- 6 kovanjem same α-amilaze in α-glukozidaze, in odcepljene, substituirane ali nesubstituirane fenole lahko nato zlahka določimo po znanih barvnih reakcijah. Izum pa je uporaben tudi pri substituentih, ki stoje v legi β. V tem primeru uporabljamo dodatno poleg α-glukozidaza tudi še βglukozidazo.Maltoheptasis derivatives, in particular the compounds of general formula I in which R does not represent a glucoside group, are also particularly suitable for this embodiment of the invention. In the action of both enzymes, α-amylase and α-glucosidase, the substituent, i.e., a phenyl group, a mononitrophenyl group, or a dinitrophenyl group, respectively. the final residue of sorbite or glucone acid is cleaved off and easily determined. Phenyl groups may be in the α- or β-position. in the case of the α-position, their cleavage is effected by the action of α-amylase and α-glucosidase itself, and the cleaved, substituted or unsubstituted phenols can then be readily determined by known color reactions. The invention is also applicable to substituents in position β. In this case, β-glucosidase is used in addition to α-glucosidases.
Pri dinitrofenilnih ostankih se lahko nahajata obe nitro skupini v poljubni legi, npr. kot 2,4-, 2,6- ali 3,5-substituenta.For dinitrophenyl residues, both nitro groups may be in any position, e.g. as 2,4-, 2,6- or 3,5-substituents.
Nitrofenoli oz. dinitrofenoli, ki nastanejo pri odcepitvi substituentov, ki vsebujejo nitro skupine, so sa me obarvane spojine, ki jih lahko brez nadaljnjega optično vNitrophenols or. dinitrophenols resulting from the cleavage of nitro-containing substituents are self-colored compounds which can be optically
določimo. Ce se odcepi fenol sam, lahko tega določimo po znanih metodah, npr. s presnovo z nukleofilnim sredstvom, kot 3-metil-6-sulfonil-benztiazolon-hidrazonom-(2) (HSK) v prisotnosti monofenoloksidaze. Pri tej reakciji nastane rdeče barvilo, ki ga lahko izmerimo.we determine. If phenol is cleaved alone, this can be determined by known methods, e.g. by metabolism with a nucleophilic agent such as 3-methyl-6-sulfonyl-benzthiazolone-hydrazone- (2) (HSK) in the presence of monophenol oxidase. This reaction produces a red dye that can be measured.
Pri odcepitvi sorbita lahko le-tega npr. s sorbitdehidrogenazo oksidiramo v fruktozo; istočasno se prisotni RAD reducira v NADH. Nastanek slednjega lahko zlahka določimo na znan način v UV spektrofotometru. če tega nimamo na razpolago, lahko s presnovo s tetrazolijevo soljo, kot npr. INT (2-(p-jodfenil)-3-(p-nitrofenil)5-fenil-tetrazolijevim kloridom) v prisotnosti diaforaze ali drugega prenašalca elektronov tvorimo tudi obarvanWhen sorbitol is cleaved, e.g. by sorbitdehydrogenase oxidized to fructose; at the same time the present RAD is reduced to NADH. The formation of the latter can be readily determined in a known manner in a UV spectrophotometer. if this is not available, the metabolism with tetrazolium salt, such as e.g. INT (2- (p-iodophenyl) -3- (p-nitrophenyl) 5-phenyl-tetrazolium chloride) is also colored in the presence of a diaphorase or other electron carrier.
-? formazan, ki ga lahko izmerimo v vidnem območju.-? formazan, which can be measured in the visible range.
Na analogen način lahko sproščeno glukonsko kislino določimo po znanih metodah, npr. z glukonat-kinazo, 6-fosfoglukonske kieline-dehidrogenazo in NADP, kot tudi v danem primeru tetrazolijevo soljo in prenašalcem elektronov.In an analogous manner, the released gluconic acid can be determined by known methods, e.g. with gluconate kinase, 6-phosphogluconic kielin dehydrogenase and NADP, as well as optionally the tetrazolium salt and electron transporter.
Za izvedbo postopka v smislu izuma so na splošno primerne pH vrednosti med 5 in 9· Prednostno delamo pri pfl vrednostih med 7 in 7»5» ker dobimo pri tem najboljše rezultate in najkrajše reakcijske čase. če uporabimo v smislu izuma nitrofenilne spojine, je območje primernih pH vrednosti nekoliko ožje in leži na splošno med pH 6 in pH 8,5.In general, pH values between 5 and 9 are suitable for carrying out the process of the invention. · Preferably, we operate at pfl values between 7 and 7 "5" because we obtain the best results and the shortest reaction times. when used in the invention of the nitrophenyl compound, the range of suitable pH values is slightly narrower and generally lies between pH 6 and pH 8.5.
Kot puferji so primerni tisti, ki so učinkoviti v območju glavne aktivnosti uporabljenih encimov. Prednostni so fosfat, HEPES (N-(2-hidroksietil)-piperazin-N-2etansulfonska kislina) in glicilglicin. Prednostne koncentracije so med 10 in 200 mM/1.Suitable as buffers are those that are effective in the range of major activity of the enzymes used. Preferred are phosphate, HEPES (N- (2-hydroxyethyl) -piperazine-N-2ethanesulfonic acid) and glycylglycine. Preferred concentrations are between 10 and 200 mM / l.
α-glukozidazo uporabljamo na splošno v količinah med 0,1 in 5000 U/ml. Posebna prednost postopka v smis lu izuma je v tem, da lahko uporabimo relativno velike količine tega encima, tako, da je stopnja, ki določa hitrost cepitev z α-amilazo. Seveda je možna uporaba še večjih količin tega encima, vendar pa s tem ne dosežemo nobenih nadaljnjih prednosti več.α-glucosidase is generally used in amounts between 0.1 and 5000 U / ml. A particular advantage of the process of the invention is that relatively large amounts of this enzyme can be used such that it is a step that determines the rate of α-amylase cleavage. Of course, even greater amounts of this enzyme can be used, but this does not bring us any further benefits any more.
-όSpojine s splošno formulo I, ki jih uporabljamo v smislu izuma, uporabimo v testu na splošno v količinah med 0,1 in 250 mM/Ι. Prednostne so količine med 0,5 in 100 mM/1.Compounds of general formula I used in the invention are generally used in the assay in amounts of between 0.1 and 250 mM / Ι. Quantities between 0.5 and 100 mM / l are preferred.
Nasičenje substrata a-amilaze z maltoheptaozo leži pri koncentraciji 8 do 10 mM. Smotrno uporabljamo zato minimalno koncentracijo 8 mM maltoheptaoze, če naj delamo pri pogojih nasičenosti substrata, kar se redno dogaja.The saturation of the α-amylase substrate with maltoheptasis lies at a concentration of 8 to 10 mM. Therefore, a minimum concentration of 8 mM maltoheptasis is reasonably used if we are to operate under substrate saturation conditions, which happens regularly.
Bazen tega smotrno dodamo aktivirao sredstvo za α-amilazo. Tovrstna aktivirna sredstva so znana. Prednostna sta natrijev klorid ali kalijev klorid.An activated α-amylase agent is conveniently added to the pool. Such activating agents are known. Sodium chloride or potassium chloride are preferred.
Pri nadaljnji prednostni izvedbeni obliki postopka v smislu izuma se vrši določitev proizvodov cepitve s presnovo z maltozefosforilazo ob tvorbi glukoze-1-fosfata, ki ga nato določimo na znan način. Po posebno prednostni izvedbeni obliki se vrši določitev glukoze-1-fosfata s pretvorbo v glukoze-6-fosfat s pomočjo β-fosfoglukoze-mutaze, oksidacijo nastalega glukoze-6-fosfata z NAD v prisotnosti glukoze-6-fosfat-dehidrogenaze ob tvorbi glukonat-6-fosfata in NADH, pri čemer tvorbo NADH zlahka spremljamo fotometrično. Merilni signal lahko še okrepimo z nadaljnjo 0ksidacijo z NAD v prisotnosti 6-fosfoglukonat-dehidrogenaze ob tvorbi ribuloze-5-fosfata in nadaljnje molekule NADH.In a further preferred embodiment of the process of the invention, the cleavage products of the maltosephosphorylase metabolite are formed to form glucose-1-phosphate, which is then determined in a known manner. In a particularly preferred embodiment, glucose-1-phosphate is determined by conversion to glucose-6-phosphate by β-phosphoglucose-mutase, oxidation of the resulting glucose-6-phosphate by NAD in the presence of glucose-6-phosphate-dehydrogenase upon gluconate formation -6-phosphate and NADH, the NADH formation being easily monitored photometrically. The measurement signal can be further enhanced by further oxidation with NAD in the presence of 6-phosphogluconate dehydrogenase to form ribulose-5-phosphate and a further NADH molecule.
Princip te izvedbene oblike podajajo sledeče enačbe:The principle of this embodiment is given by the following equations:
maltoheptaoza + 1^0 β·3111*-323^ maltotriaza + maltotetraoza -> maltoza maltoza + PO^ 5-“Sl^efosforilaza^ glukoza + β-ginko z e-1-P β-glukoze-l-P β-PGluM,^ ginkoze-6-Ρ glukoze-6-Ρ + NAD+ glukonat-6-Ρ + NADH + H+ glukonat-6~P+NAD+ ribuloze-^-^+NADH + H+ maltoheptasis + 1 ^ 0 β · 3111 * - 323 ^ maltotriase + maltotetraose -> maltose maltose + PO ^ 5- “Sl ^ phosphorylase ^ glucose + β-ginkgo with e-1-P β-glucose-lP β-PGluM, ^ of glucose-6-Ρ glucose-6-Ρ + NAD + gluconate-6-Ρ + NADH + H + gluconate-6 ~ P + NAD + ribulose - ^ - ^ + NADH + H +
Prednost te izvedbene oblike izuma je v tem, da je maltozefosforilaza bolj specifična kot a-glukozidaza in zato ne moti endogene glukoze.An advantage of this embodiment of the invention is that maltosephosphorylase is more specific than α-glucosidase and therefore does not interfere with endogenous glucose.
Glede puferja velja na enak način tisto, kar smo navedli za izvedbeno obliko postopka v smislu izuma po načinu dela z a-glukozidazo.With respect to the buffer, what has been stated in the same manner as the embodiment of the process of the invention according to the α-glucosidase method is applied.
Reagent za določitev α-amilaze vsebuje substrat α-amilaze in sistem za določitev enega od proizvodov cepitve, ki ga tvori α-amilaza iz substrata amilaze, pri čemer substratThe α-amylase determination reagent comprises an α-amylase substrate and a system for determining one of the cleavage products formed by α-amylase from the amylase substrate, the substrate being
- 10 substrata α-amilaze, ki je označen s tem, da sestoji substrat iz spojine s splošno formulo I.- 10 α-amylase substrates, characterized in that the substrate consists of a compound of general formula I.
Prednostni sistem za določitev proizvodov cepit ve je sistem α-glukozidaze, ki vsebuje α-glukozidazo, alka lijski klorid in pufer. Če sestoji substrat iz maltoheptaoze same, so potrebni kot encimi še heksokinaza (HK) in glukoze-6-fosfat-dehidrogenaza (G6PDH), kot tudi NAD, ATP in magnezij.The preferred system for determining the products of cepit ve is the α-glucosidase system containing α-glucosidase, alkali chloride and buffer. If the substrate consists of maltoheptasis itself, hexokinase (HK) and glucose-6-phosphate dehydrogenase (G6PDH), as well as NAD, ATP and magnesium, are required as enzymes.
Prednostno sestoji reagent na osnovi sistema aglukozidaze iz x 105 do 3 x 10* U/l a-glukozidaze,Preferably, the reagent is based on the aglucosidase system from x 105 to 3 x 10 * U / l α-glucosidase,
105 do 5 x 10* HK,10 5 to 5 x 10 * HK,
105 do 5 x 10* G6PDH,10 5 to 5 x 10 * G6PDH,
0,5 do 8 mM/Ι NAD,0.5 to 8 mM / Ι NAD,
0,5 do 5 mM/Ι ATP, do 3 mM/Ι Mg2+ do 100 mM/Ι NaCI ali KC1, do 200 mM/Ι puferja, pH 6,2 do 7»8, in do 100 mM/Ι maltoheptaoze ali njegovega mnogokratnika ali ulomka, v suhi ali raztopljeni obliki.0.5 to 5 mM / Ι ATP, up to 3 mM / Ι Mg 2+ to 100 mM / Ι NaCI or KC1, up to 200 mM / Ι buffer, pH 6.2 to 7 8 8, and up to 100 mM / Ι maltoheptosis or a multiple or fragment thereof, in the dry or dissolved form.
Pri drugi prednostni izvedbeni obliki sestoji reagent iz α-glukozidaze, KC1 ali NaCI, puferja in sub2 6 strata. Tovrstni reagent vsebuje zlasti 10 do 5 x 10 U/l α-glukozidaze, 1 do 100 mM/Ι NaCl ali KC1, 10 do 250 mM/1 puferja, pH 5 do 9, in 0,1 do 250 mM/Ι derivata maltoheptaoze s splošno fcrmulo I, računano na koncentracijo v testu. Reagent ae lahko nahaja v suhi, zlasti liofilizirani obliki, ali v obliki raztopine, kot mešanica vseh sestavin ali ločeno.In another preferred embodiment, the reagent consists of α-glucosidase, KC1 or NaCI, buffer and sub2 6 strata. In particular, this reagent contains 10 to 5 x 10 U / l α-glucosidase, 1 to 100 mM / Ι NaCl or KC1, 10 to 250 mM / 1 buffer, pH 5 to 9, and 0.1 to 250 mM / mal of the maltoheptoose derivative with general fcrmula I calculated on the concentration in the assay. The reagent may be present in dry, especially lyophilized form, or in solution form, as a mixture of all the ingredients or separately.
Po nadaljni izvedbeni obliki vsebuje reagent gornje vrste dodatno še β-glukozidazo ali/in fenoloksidazo in HSK.In a further embodiment, the reagent of the above type further comprises β-glucosidase or / and phenoloxidase and HSK.
Po nadaljnji izvedbeni obliki izuma vsebuje reagent poleg α-glukozidaze, NaCl ali KC1, puferja in substrata še sorbitdehidrogenazo in NAD ali glukonat-kinazo, ATP, 6-fosfoglukonske kisline dehidrogenazo in NADP, kot tudi v danem primeru tetrazolijevo sol in diaforazo oz. fenazinmetesulfat (PMS).According to a further embodiment of the invention, the reagent contains, in addition to α-glucosidase, NaCl or KC1, buffer and substrate, sorbitdehydrogenase and NAD or gluconate kinase, ATP, 6-phosphogluconic acid dehydrogenase and NADP, as well as optionally tetrazolium salt and diaphoresis. phenazinmetesulfate (PMS).
Prednostni reagent take vrste vsebuje 1 x 10 do 3 χ 106 U/l α-glukozidaze, 2 x 10^ do 5 * 10^ U/l sorbitdehidrogenaze, 1 x 10y do 5 x 10 U/l heksokinaze, 0,5 do 50 mM/Ι ATP, 10 do 500 U/l diaforaze (Chlostridium Kluyveri), 0,01 do 0,5 mM/Ι tetrazolijeve soli, 0,1 do 10 mM/Ι NAD,A preferred reagent of this type contains 1 x 10 to 3 χ 10 6 U / l α-glucosidase, 2 x 10 ^ to 5 * 10 ^ U / l sorbitdehydrogenase, 1 x 10 y to 5 x 10 U / l hexokinase, 0.5 up to 50 mM / Ι ATP, 10 to 500 U / l diaphoresis (Chlostridium Kluyveri), 0.01 to 0.5 mM / Ι tetrazolium salts, 0.1 to 10 mM / Ι NAD,
0,2 do 5 mM/Ι MgC^, 0,5 do 20 mM/Ι maltoheptita, 1 do 100 mM/Ι NaCl ali KC1 in 10 do 250 mM/Ι pufer ja, pH 5,5 do 8,5.0.2 to 5 mM / Ι MgC ^, 0.5 to 20 mM / Ι maltoheptite, 1 to 100 mM / Ι NaCl or KC1, and 10 to 250 mM / Ι buffer, pH 5.5 to 8.5.
V danem primeru je prisotno še neionsko površinsko aktivno sredstvo v količini med 5 in 50 mM/1.In the present case, a non-ionic surfactant in an amount of between 5 and 50 mM / l is present.
- 12 Prav tako prednostna izvedbena oblika vsebuje 100 do 5 * 106 U/l a-glukozidaze, 10 do 10^ U/l 6-fosfoglukonat-debidrogenaze, 20 do 2 x 10^ U/l glukonat-kinaze, 0,5 do 25 mM/Ι ATP, 0,05 do 1,0 mM/Ι NADP, 1,0 do 20 mM/1 maltoheptaglukonske kisline, 0,5 do 5 mM/Ι MgClg, 1 do 100 mM/Ι NaCl in 10 do 250 mM/Ι pufer ja, pH 5» 5 do 8,5.- 12 Also, the preferred embodiment contains 100 to 5 * 10 6 U / l α-glucosidase, 10 to 10 ^ U / l 6-phosphogluconate debidrogenase, 20 to 2 x 10 ^ U / l gluconate kinase, 0.5 up to 25 mM / Ι ATP, 0.05 to 1.0 mM / Ι NADP, 1.0 to 20 mM / 1 maltoheptagluconic acid, 0.5 to 5 mM / Ι MgClg, 1 to 100 mM / Ι NaCl, and 10 to 250 mM / fer buffer, pH 5 »5 to 8.5.
Nadaljnji reagent vsebujeFurther reagent contains
0,1 do 250 mM/1 a-nitrofenil-maltoheptaozida ali dinitrof eni 1-maltoheptao zida, x 10^ do 2,5 x 106 U/l a-glukozidaze, do 100 mM/Ι natrijevega klorida ali kalijevega klorida in 10 do 250 mM/Ι fosfatnega puferja, pH 7,0 do 8,0.0.1 to 250 mM / l of α-nitrophenyl maltoheptaozid or dinitrophic 1-maltoheptao wall, x 10 ^ to 2.5 x 10 6 U / l of α-glucosidase, up to 100 mM / Ι of sodium chloride or potassium chloride and 10 up to 250 mM / Ι phosphate buffer, pH 7.0 to 8.0.
Še druga izvedbena oblika reagenta vsebuje:Another embodiment of the reagent comprises:
0,1 do 250 mM/Ι a-fenilmaltoheptaozida, χ 102 do 1,5 x 10θ U/l a-glukozidaze, do 10^ U/l monofenoloksidaze,0.1 to 250 mM / Ι α-phenylmaltoheptaozide, χ 10 2 to 1.5 x 10θ U / l α-glucosidase, to 10 ^ U / l monophenol oxidase,
0,1 do 10 mMl/1 HSK, do 100 mM/Ι NaCl ali ZC1 in do 250 mM/Ι puferja.0.1 to 10 mMl / 1 HSK, up to 100 mM / Ι NaCl or ZC1, and up to 250 mM / Ι buffer.
Drug prednostni sistem za določitev proizvodov cepitve je sistem maltozefosforilaze, ki sestoji v bistvu iz maltozefosforilaze, β-fosfoglukomutaze (PFMG), glukoze6-fosfat-dehidrogenaze (G6PDH), glukoze-1,6-difosfataAnother preferred system for determining cleavage products is a maltosephosphorylase system consisting essentially of maltosephosphorylase, β-phosphoglucomutase (PFMG), glucose6-phosphate-dehydrogenase (G6PDH), glucose-1,6-diphosphate
- 13 (G1, 6DP), NAD, pufer ja, maltoheptaoze in v danem primeru- 13 (G1, 6DP), NAD, buffer, maltoheptosis and, as appropriate
6-fosfoglukonat-dehidrogenaze (6PGDH).6-phosphogluconate dehydrogenase (6PGDH).
Posebno prednostni reagent s tem sistemom za dokazovanje sestoji izA particularly preferred reagent with this proofing system consists of
0,5 x 10* do 20 x 10* U/l malto|zefosforilaze, χ 102 do 1 x 104 β-FGluM, x 10 do 3 x 10 U/l glukoze-6-f osf at-dehidrogenaze,0.5 x 10 * to 20 x 10 * U / l mortar | zephosphorylase, χ 10 2 to 1 x 10 4 β-FGluM, x 10 to 3 x 10 U / l glucose-6-f osf at-dehydrogenase,
0,5 do 10 mM/Ι NAD,0.5 to 10 mM / Ι NAD,
0,001 do 1 mM/Ι glukoze-1,6-difosfata,0.001 to 1 mM / Ι of glucose-1,6-diphosphate,
0,5 do 100 mM/Ι puferja, pH 6,0 do 7,5, do 50 mM/Ι maltoheptaoze in v danem primeru 2 4 x 10 do 1 x 10 U/l 6-fosfoglukonat-dehidrogenaze.0.5 to 100 mM / Ι buffer, pH 6.0 to 7.5, up to 50 mM / Ι maltoheptose, and optionally 2 4 x 10 to 1 x 10 U / l 6-phosphogluconate dehydrogenase.
Reagent se lahko nahaja v suhi ali raztopljeni obliki, lahko pa se nahaja tudi impregniran na listastem nosilcu, npr. foliji, vpojnem papirju ali podobno. V tem primeru .sestoji smotrno iz vsaj treh plasti oz. slojev, pri čemer vsebuje prvi sloj substrat, drugi sloj rabi kot zaporni sloj in tretji sloj vsebuje sistem za določitev proizvodov cepitve. Če spravimo tak večslojni reagenčni material, ki je primeren za preprost hitri test na α-amilazo, v stik s tekočim skuskom, ki vsebuje aamilazo, razcepi α-amilaza substrat, in proizvodi cepitve difundirajo skozi vmesni sloj v tretji sloj, ki vsebujeThe reagent may be present in dry or dissolved form or may be impregnated on a sheet carrier, e.g. foil, absorbent paper or the like. In this case, it consists of at least three layers, respectively. layers, the first layer having a substrate, the second layer being used as a barrier layer and the third layer having a system for determining the fission products. If such a multilayer reagent material suitable for a simple rapid α-amylase test is brought into contact with the amylase-containing liquid mackerel, the α-amylase cleaves the substrate and the cleavage products diffuse through the intermediate layer into the third layer containing
- 14 določevalni sistem« Kot dokazilno reakcijo uporabimo v tem primeru smotrno reakcijo, pri kateri pride do obarvanja, da bi z nastalo spremembo barve hapravili koncentracijo a-amilaze vizualno vidno, v kolikor proizvodi cepitve niso že sami obarvani.- 14 Determination System «In this case, a sensible staining reaction is used, in order to arrest the α-amylase concentration visually by the resulting discoloration, if the cleavage products are not already stained.
V smislu izuma uporabljene derivate maltoheptaoze lahko pripravimo po različnih metodah. V kolikor gre za fenilirane derivate, lahko uporabimo tako kemijske kot tudi encimatske metode. Kemijska sinteza temelji načelno na presnovi peracetilirane maltoheptaoze z ustreznim fenolom v prisotnosti Friedel-Craftsovega katalizatorja. Ta metoda je primerna tako za fenol sam kot tudi za mononitrofenol in dinitrofenol. Alternativno je možno tudi, da najprej pripravimo fenilni derivat in tega nato nitriramo, npr. po postopku, opisanem v Buli. Chem. Soc. Japan 34. (1961) 781.According to the invention, the maltotheptase derivatives used can be prepared by various methods. In the case of phenylated derivatives, both chemical and enzymatic methods can be used. Chemical synthesis is based in principle on the metabolism of peracetylated maltoheptasis with the corresponding phenol in the presence of the Friedel-Crafts catalyst. This method is suitable for both phenol alone and mononitrophenol and dinitrophenol. Alternatively, it is also possible to first prepare a phenyl derivative and then nitrate it, e.g. according to the procedure described in Bula. Chem. Soc. Japan 34. (1961) 781.
Ta metoda je primerna zlasti za mononitro-derivat, pri čemer lahko morebiti izvedemo ločenje nastalih o- in p-nitrofenilnih derivatov.This method is particularly suitable for the mononitro derivative, where it is possible to separate the resulting o- and p-nitrophenyl derivatives.
Prednostno izvedemo to presnovo s taljenjem ali kuhanjem ob ref luksu v nepolarnem topilu s ZnC^, SnCl^ ali TiCl^ kot Friedel-Craftsovim katalizatorjem. Po uvedbi fenola oz. nitrofenola odcepimo na znan način zaščitne skupine, npr. z natrijevim metilatom, amoniakom, KOH ali barijevim metoksidom, vsakokrat v metanolni raztopini, z vodno raztopino barijevega hidroksida itd.Preferably, this reaction is carried out by melting or boiling at reflux in a non-polar solvent with ZnC ^, SnCl ^ or TiCl ^ as a Friedel-Crafts catalyst. After the introduction of phenol or. the nitrophenol is cleaved in a known manner by a protecting group, e.g. with sodium methylate, ammonia, KOH or barium methoxide, each in methanol solution, with aqueous barium hydroxide solution, etc.
-15Encimatska priprava fenilnih derivatov se vrši s transglukozidiranjem fenilglukozida oz. ustreznih nitriranth fenilglukozidov z α-ciklodekstrinom, amilazo ali topnim škrobom v prisotnosti specifične mikrobne transferaze. Prednostno uporabljamo zajto transferazo iz Bacillus macerans. Pri tem lahko zato transglukozidiranje uporabimo znano amilazo mikroba Bacillus macerans (E.C. 2.4.1.19. DSM 24; izoliranje: J.A. de Pinto, L.L. Campbell, Biochemistry 2» (1968) 114; transferna reakcija: Methods in Carbohydr. Chemistry, Vol. II, 54?), ki kaže poleg svojega hidrolitekega in ciklizirnega učinka očitno tudi glukozi1transferentno učinkovitost.-15Enzymatic preparation of phenyl derivatives is carried out by transglucosidation of phenylglucoside or. of corresponding nitriranth phenylglucosides with α-cyclodextrin, amylase or soluble starch in the presence of a specific microbial transferase. Preferably, a rabbit transferase from Bacillus macerans is used. Therefore, the known amylase of Bacillus macerans microbe (EC 2.4.1.19. DSM 24; isolation: JA de Pinto, LL Campbell, Biochemistry 2 »(1968) 114 can be used for transglucosidation; transfer reaction: Methods and Carbohydr. Chemistry, Vol. II. 54?), Which, in addition to its hydrolytic and cyclizing effect, also exhibits glucose1transferential efficacy.
Tisto spojino s formulo I, v kateri predstavlja R sorbitni ostanek, lahko pripravimo iz maltoheptaoze z redukcijo z natrijevim borovim hidridom (NaBH^) pri prizanesljivih pogojih.The compound of formula I in which R represents the sorbitol moiety can be prepared from maltoheptasis by reduction with sodium boron hydride (NaBH 4) under favorable conditions.
II
Spojino s formulo I, v kateri predstavlja R skupino glukonske kisline, lahko končno pripravimo kemijsko ali encimatsko po znanih metodah za pripravo glukonske kisline iz maltoheptaoze, npr. z oksidacijo z bromom (Methods in Carbohydr. Chemistry, Vol. II, 15)·A compound of formula I in which R represents a gluconic acid group can finally be prepared chemically or enzymatically by known methods for the preparation of gluconic acid from maltoheptosis, e.g. by oxidation with bromine (Methods in Carbohydr. Chemistry, Vol. II, 15) ·
Kot smo že omenili, z izumom ni ustvarjen samo hiter in specifičen postopek za določitev α-amilaze, temveč je zlasti popolnoma ali daljnosežno odstranjena lag- 16 faza, kar je posebno pomembno pri uporabi postopka v anali znih avtomatih. Poleg tega se da izvesti postopek v smis lu izuma v mnogih izvedbenih oblikah brez kompliciranih aparatur za ovrednotenje in je zato primeren zlasti za hitre diagnostike in za optično določitev v vidnem območju. Istočasno pa se dajo različne izvedbene oblike postopka v smislu izuma izvesti tudi z UV merilnimi pripravami. Nadaljnji prednosti sta stroga proporcialnost in dejstvo, da kemijsko sorodne snovi, ki jih vsebuje kri, ne povzročajo nobenih motenj.As mentioned above, the invention not only creates a rapid and specific method for the determination of α-amylase, but particularly the complete or far-reaching removal of the lag-16 phase, which is particularly important when using the procedure in assays. Furthermore, the process of the invention can be carried out in many embodiments without complicated evaluation apparatus and is therefore particularly suitable for rapid diagnostics and optical sighting. At the same time, various embodiments of the process of the invention can also be performed with UV measuring devices. Further advantages are the strict proportionality and the fact that the chemically related substances contained in the blood do not cause any disturbance.
V smislu izuma uporabljene substrate se da dobiti zlahka in z veliko čistoto. Preprost postopek za pripravo maltoheptaoze je opisan v nemški patentni prijavi P 27 41 191.2. Postopek je primeren za določitev a-amilaze v bioloških tekočinah, kot serumu, heparinski plazmi, urinu in pod., ali v drugih tekočih ali trdnih materialih.The substrates used in the invention can be obtained easily and with great purity. A simple process for the preparation of maltoheptasis is described in German patent application P 27 41 191.2. The process is suitable for the determination of α-amylase in biological fluids, such as serum, heparin plasma, urine and the like, or in other liquid or solid materials.
Naslednji primeri pojasnjujejo izum.The following examples illustrate the invention.
-17 PRIMER 1-17 EXAMPLE 1
Maltogena metoda (sistem a-glukozidaze)Maltogenic method (α-glucosidase system)
Reagenčno mešanico, ki vsebuje α-glukozidazo, G6PDH, HK, NAD, ATP, maltoheptaozo, Mg2+, NaCI in fosfatni pufer, raztopimo v 2,0 ml destilirane vode. Obstojnost reagenta pri sobni temperaturi znaša okoli 1 uro, pri tem peraturah pod 8 °C 6 ur.The reagent mixture containing α-glucosidase, G6PDH, HK, NAD, ATP, maltoheptasis, Mg 2+ , NaCI and phosphate buffer was dissolved in 2.0 ml of distilled water. The stability of the reagent at room temperature is about 1 hour, with peratures below 8 ° C for 6 hours.
Dobljena raztopina ima naslednje koncentracijeThe resulting solution has the following concentrations
Raztopim! dodamo pri 25 °C 0,02 ml skuska seruma, jo prenesemo v kiveto z debelino plasti 1 cm in nato v fotometru določimo ekstinkcijo pri Hg 365 nm, 340 nm ali Hg 334 nm. Po 10 minutah odčitamo ekstinkcijo in potem ponovimo odčitanje v presledkih po 1 minuto petkrat.I dissolve! 0.02 ml of mackerel serum was added at 25 ° C, transferred to a cuvette with a layer thickness of 1 cm, and then the extinction was determined in the photometer at Hg 365 nm, 340 nm or Hg 334 nm. After 10 minutes, read the extinction and then repeat the reading at intervals of 1 minute five times.
-18Ιζ tako ugotovljenih razlik ekstinkcije na minuto ( Δε/min), izračunamo srednjo vrednost, odštejemo prazno vrednost reagenta in korigirano vrednost vstavimo v izračun. Izračun se vrši takole:-18Ιζ of the extinction differences found per minute (Δε / min), calculate the mean, subtract the empty reagent value and insert the corrected value into the calculation. The calculation is as follows:
U/l 25°C = 4244 x P E 365 nm/min = 2290 x0E 340 nm/min e 2335 χΔε 334 nm/minU / l 25 ° C = 4244 x PE 365 nm / min = 2290 x0E 340 nm / min e 2335 χΔε 334 nm / min
Sl. 1 kaže rezultate vrste razredčin Človeškega seruma s fiziološko raztopino kuhinjske soli, ki jih dobimo po tej metodi.FIG. 1 shows the results of a series of human serum dilutions with saline obtained by this method.
Če razdelimo reagent na dva dela, od katerih vsebuje eden maltoheptaozo in drugi mešanico vseh ostalih reagentov, lahko obstojnost raztopin, ki jih z njimi priI pravimo, zvečamo. Za mešanico reagentov znaša pri temperaturah do 8 °C 50 ur, pri sobni temperaturi okoli 8 ur. Obstojnost raztopine maltoheptaoze znaša ustrezno 6 tednov oz. okoli 1 teden.If we divide the reagent into two parts, one of which contains maltoheptasis and the other a mixture of all other reagents, the stability of the solutions called them can be increased. For the reagent mixture, the temperature at temperatures up to 8 ° C is 50 hours, at room temperature about 8 hours. The stability of the solution of maltoheptasis is 6 weeks, respectively. about 1 week.
PRIMER 2EXAMPLE 2
Določitev s sistemom maltoze_f0sforilazeDetermination with the maltose_f 0 system of sophylase
Pripravili smo dva reagenta, ki sestojita iz substrata amilaze in sistema maltoze-fosforilaze. En reagent je vseboval substrat maltoheptaoze, drugi ustrezno ejr stanju tehnike topni škrob. Koncentracija reagentov po raz tapljanju v vodi je bila naslednja:Two reagents were prepared consisting of an amylase substrate and a maltose phosphorylase system. One reagent contained a maltoheptoase substrate, the other a soluble starch suitable for the art. The concentration of reagents after dissolution in water was as follows:
izum primerjavainvention comparison
mesent)mesent)
Dobljeno raztopino smo inkubirali pri 30 °C, ji dodali raztopino skuska in določili v fotometru razliko ekstinkcij pri Hg 334 nm. Po 10-minutni predinkubaci ji smo merili razliko ekstinkci j v teku 10 minut Za 2,0 ml reagenta in 0,10 ml skuska velja nato naslednja formula za izračunavanje ;-οπ=ΔΕ/π1η x 1699 U/1 The resulting solution was incubated at 30 ° C, mackerel solution was added and the difference in extinction at Hg 334 nm was determined in the photometer. After a 10-minute preincubation, the difference in extinction was measured over a 10-minute period. The following formula was then applied to 2.0 ml of reagent and 0.10 ml of mackerel; -οπ = ΔΕ / π1η x 1699 U / 1
- 20 Pri uporabi petih različnih človeških serumov smo ugotovili z zgornjimi reagenti naslednje vrednosti:- 20 When using five different human sera, the following reagents were determined with the above reagents:
PRIMER 3EXAMPLE 3
Priprava a-fenilmaltoheptaozidaPreparation of α-phenylmaltoheptaozide
a) Tridekozacetil-p-D-maltoheptaozaa) Tridecosacetyl-p-D-maltoheptasis
57»6 g (50 mM) maltoheptaoze in 41 g (500 mM) hrezvodnega natrijevega acetata suspendiramo v 543 ml (5*75 mola) i anhidrida ocetne kisline in 4 ure ob izključitvi vlage močno mešamo pri 100 °C. Po ohlajen ju na okoli 60 °C vmešamo v okoli 1 1 ledene vode in mešamo preko noči pri 4 °C, pri čemer se obori žilava, polkristalinicna masa· Po oddekantiranju supematanta znova zmešamo ostanek z ledeno vodo. Pri tem proizvod popolnoma izkristalizira. Proizvod ločimo, izperemo in posušimo.57 »6 g (50 mM) of maltoheptoase and 41 g (500 mM) of refreshing sodium acetate were suspended in 543 ml (5 * 75 mol) of acetic anhydride and stirred vigorously at 100 ° C for 4 hours. After being cooled to about 60 ° C, they are stirred in about 1 L of ice water and stirred overnight at 4 ° C, leaving a tough, semi-crystalline mass precipitated · After decanting the supernatant, mix the residue again with ice water. The product crystallizes completely. The product is separated, washed and dried.
Dobitek 80,7 g (76 % teor.) brezbarvni kristali [a]pT » + 137,5 0 (c « 1,15 kloroform), tal. - 150 0 (neostri,Yield 80.7 g (76% of theory) colorless crystals [a] p T »+ 137,5 0 (c« 1,15 chloroform), m.p. - 150 0 (sharp,
- 21 Matično lužnico (dekantat) uparimo v vakuumu do suhega in ostanek prav tako zdrgnemo z ledeno vodo in kristaliziramo.- 21 The mother liquor (decantate) was evaporated in vacuo to dryness and the residue was also crushed with ice water and crystallized.
Dobitek 22,5 gYield 22.5 g
Ca]pT - 156 0 (c - 1, kloroform), tal. 150 °C.Ca] p T - 156 0 (c - 1, chloroform), m.p. 150 ° C.
Celotni dobitek 105 g » 97 % teor.Total yield 105 g »97% of theory.
Proizvod lahko prekristaliziramo iz etanola, pri čemer se tudi po večkratnem prekristaliziranju tališče in sučnost ne spremenita. Proizvod je torej ob atomu C^ optično enotno (β) konfiguriran.The product may be recrystallized from ethanol without recrystallizing again after melting and dryness. The product is therefore optically uniquely configured at the C ^ atom.
b) Dodekozacetil-a-fenil-D-maltoheptaozidb) Dodecosacetyl-α-phenyl-D-maltoheptaozide
9,54 g (4,5 mM) tridekozacetil-P-D-maltoheptaoze, 0,61 g (4,5 mM) sveže staljenega ZnClg in 4,25 g (4-5 mM) destiliranega fenola mešamo ob izključitvi vlage 2,5 ur pri 100 °C. Nato še toplo raztopimo v etilacetatu in izperemo s po 2 x 100 ml HgO, 5 x 100 ml 1 n NaOH, 100 ml 1 n ocetne kisline in 100 ml nasičene raztopine natrijevega klorida. Sprva rjava raztopina postane pri tem svetlo rumena. Po sušenju nad MgSO^ uparimo do suhega in prevzamemo v toplem metanolu (5θ ml). Po stanju preko noči se izloči sirupast material, ki ga kristaliziramo iz etanola.9.54 g (4.5 mM) of tridecosacetyl-PD-maltoheptoose, 0.61 g (4.5 mM) of freshly melted ZnClg and 4.25 g (4-5 mM) of distilled phenol were stirred at 2.5 h for moisture at 100 ° C. It was then warmly dissolved in ethyl acetate and washed with 2 x 100 ml HgO, 5 x 100 ml 1 n NaOH, 100 ml 1 n acetic acid and 100 ml saturated sodium chloride solution. Initially, the brown solution turns light yellow. After drying over MgSO4, evaporate to dryness and take up in warm methanol (5θ ml). The syrupy material, which is crystallized from ethanol, is recovered overnight.
Dobitek: 8,7 g (90 % teor), tal. 155 do 165 °θ (razp.) [a]pT + 147 0 (c » 8 v kloroformu).Yield: 8.7 g (90% of theory), m.p. 155 to 165 ° θ (dec.) [A] p T + 147 0 (c »8 in chloroform).
- 22 c) Fenil-a-D-maltoheptaozid- 22 c) Phenyl-a-D-maltoheptaozid
10,8 g (5 mM) peracetil-1-fenil-a-D-maltoheptaozida raztopimo v toplem v 200 ml absolutnega metanola in dodamo pri sobni temperaturi ob dodatku nekaj dioksana med mešanjem 50 ml 0,1 n natrijevega metilata in mešamo 16 ur pri sobni temperaturi. Po 20 minutah se začne proizvod izločati polkristalno« Zončno dodamo 200 ml acetona« ohladimo na 4 °C in odsesamo. Proizvod raztopimo v vodi (160 ml), razbarvamo z aktivnim ogljem in šaržno odstranimo soli s kationskim izmenjalen (Dowex 50 H+).Dissolve 10.8 g (5 mM) of peracetyl-1-phenyl-aD-maltoheptaozid in warm 200 ml of absolute methanol and add dioxane at room temperature while stirring 50 ml of 0.1 n sodium methylate and stir for 16 hours at room temperature. temperature. After 20 minutes, the product begins to secrete semi-crystalline "Add 200 ml acetone to the sun" cooled to 4 ° C and aspirated. Dissolve the product in water (160 ml), decolourise with activated carbon and batch the cation exchange salts (Dowex 50 H + ).
Dobitek: 5,6 g (91 % teor.) brezbarvnega liofilizata Dx]pT = + 176 0 (c » 10 v E20).Yield: 5.6 g (91% of theory) of a colorless lyophilisate Dx] p T = + 176 0 (c »10 in E 2 0).
Proizvod vsebuje še nekaj proste maltoheptaoze in - po HPLC-analizi (detekcija pri 254 nm) - še 2 UV-pozitivni nečistoti. Odločimo ju s kromatografijo na premreženem dekstranu (Sephadex LH20) z vodo kot eluimim sredstvom.The product also contains some free maltoheptasis and - after HPLC analysis (detection at 254 nm) - 2 more UV-positive impurities. They are separated by chromatography on cross-linked dextran (Sephadex LH20) with water as eluant.
PRIMER 4EXAMPLE 4
Pri prava p-ni trofeni1-a-D-maltoheptaozidaIn the right p-ni tropheni1-a-D-maltoheptaozid
a) Peracetil-p-nitrofenil-a-D-maltoheptaozida) Peracetyl-β-nitrophenyl-α-D-maltoheptaozide
13,6 g (20 mM) peracetil-maltoheptaoze, pripravljene po primeru 1, a), raztopimo z 11,9 g (100 mM)13.6 g (20 mM) of peracetyl-maltoheptasis prepared according to Example 1 (a) are dissolved in 11.9 g (100 mM)
- 23 p-nitrofenola v 90 ml absolutnega benzola in med mešanjem in ob izključitvi vlage dodamo 10,4 g - 4,5 ml (40 mM) SnCl^. Pri tem se obori voluminozna masa, ki pa se pri segrevanju spet raztopi· Kuhamo 1 uro pod refluksom. Pri ohlajenju se izloči žilava masa, ki po dodatku 80 ml etilacetata spet preide v raztopino. Privmešanju raztopine v 180 ml 2 n raztopine ^2^3 se ot,ori kositrov oksidhidrat. Tega odločimo ob dodatku nekaj aktivnega oglja. Vodno fazo odločimo in organsko fazo dobro izperemo, na koncu z nasičeno raztopino NaCl· Po sušenju in uparjenju raztopine dobimo smolast proizvod, ki kristalizira iz etanola. Dobitek: 6,2 g (41 % teor.), tal. = 100 °C (razpad) [a]p^ = + 131 0 (c » 1 v kloroformu).- 23 p-nitrophenol in 90 ml of absolute benzene and 10.4 g - 4.5 ml (40 mM) of SnCl2 are added while stirring and while removing the moisture. The volume is precipitated, which dissolves again when heated. · Boil for 1 hour under reflux. When cooled, a tough mass is eliminated which, after the addition of 80 ml of ethyl acetate, is again converted into solution. By stirring the solution in 180 ml of 2 n solution ^ 2 ^ 3 , tin oxide hydrate is removed. This is decided by adding some activated charcoal. The aqueous phase was decided and the organic phase was washed thoroughly, finally with saturated NaCl solution. · After drying and evaporating the solution, a resinous product was obtained which crystallized from ethanol. Yield: 6.2 g (41% of theory), m.p. = 100 ° C (decomposition) [a] p ^ = + 131 0 (c »1 in chloroform).
Proizvod dobimo tudi, če izvedemo nastavek v kloroformu ali s TiCl^ namesto SnCl^.The product is also obtained by performing the nozzle in chloroform or with TiCl ^ instead of SnCl ^.
b) p-nitrofenil-a-D-maltoheptaozidb) p-nitrophenyl-α-D-maltoheptaozide
5,5 g (7 mM) peracetil-p-nitrofenil-maltohepta*· ozida suspendiramo v 100 ml absolutnega metanola in dodamo 5 ml okoli 1 n raztopine natrijevega metilata. Izhodni material postane podoben medu in se počasi raztopi, čez nekaj časa se začne kristalno izločanje dezacetiliranega proizvoda, ki je po mešanju preko noči popolno. Odsesamo, izperemo z metanolom in posušimo.5.5 g (7 mM) of peracetyl-p-nitrophenyl-maltohept * · ozide were suspended in 100 ml of absolute methanol and 5 ml of about 1 n sodium methylate solution was added. The starting material becomes honey-like and slowly dissolves, after a while crystalline precipitation of the deacetylated product begins, which is complete after stirring overnight. Suction off, rinse with methanol and dry.
- 24 Dobitek 2,8 g (86 % teor) [<χ]ξΤ - + 124 0 (c - 0,6 v HgO).- 24 Yield 2.8 g (86% of theory) [<χ] ξ Τ - + 124 0 (c - 0.6 in HgO).
Proizvod očistimo na premreženem dekstranu (Sephadex LH20) z vodo kot eluirnim sredstvom. Dobimo 1,2 g (45 %) zgoraj opisane spojine, ki je v encimatskem testu kktivna. Bazen tega smo dobili spojino tudi z nitriranjem α-fenilmaltoheptaozida iz primera 1 z nitrirno kislino po Buli. Chem. Soc. Japan 34 (1961) 718·The product was purified on cross-linked dextran (Sephadex LH20) with water as eluant. 1.2 g (45%) of the compound described above are obtained which are inactive in the enzymatic assay. The pool of this was also obtained by the nitration of α-phenylmaltoheptaozid from Example 1 with Bula nitric acid. Chem. Soc. Japan 34 (1961) 718 ·
Ob uporabi dinitrofenola namesto mononitrofenola dobimo ustrezne dinitrofenilne spojine.Applying dinitrophenol instead of mononitrophenol gives the corresponding dinitrophenyl compounds.
PRIMER 5 p-nitrofenil-a-maltooligosaharidi z encimatsko sintezo z amilazo iz Bacillus macerans (E.C.2.4.1.19 iz Bac. mac.EXAMPLE 5 p-Nitrophenyl-α-maltooligosaccharides by enzymatic synthesis with amylase from Bacillus macerans (E.C.2.4.1.19 from Bac. Mac.
DSM 24).DSM 24).
Amilaza iz Bacillus macerans ima poleg, ihidrolitskega in ciklizirnega učinka tudi lastnosti transferiranja. glikozila, ki jih lahko izkoristimo za sintezo oligosaharidov in derivatov oligosaharidov (Methods in Carbohydrate Chemistry II, 347). Za sintezo p-nitrofenil-oligosaharidov smo ta postopek optimirali takole:Amylase from Bacillus macerans also has transfer properties, in addition to their hydrolitic and cyclizing effects. glycosyls that can be utilized for the synthesis of oligosaccharides and oligosaccharide derivatives (Methods and Carbohydrate Chemistry II, 347). For the synthesis of p-nitrophenyl oligosaccharides, this procedure was optimized as follows:
Pomešamo 680 mg amilaze iz Bacillus macerans (E.C.2.4.1.19 iz Bac. mac. DSM 24)((liofilizat) ( odtehtek 0,46 U/mg, vsebnost proteinov v odtehtku 28,5 %, brez aktivnosti, ki cepijo p-nitrofenil-a-D-glukozid),Mix 680 mg of amylase from Bacillus macerans (EC2.4.1.19 from Bac. Mac. DSM 24) ((lyophilisate) (0.46 U / mg weight, protein content in weight 28.5%, without p-nitrophenyl cleavage activity) -aD-glucoside),
- 25 400 mg α-D-p-nitrofenilglukozida,- 25 400 mg α-D-β-nitrophenylglucoside,
3,5 g α-ciklodekstrina, in ml Soerensenovega fosfatnega pufer ja, pH 6,2; 0,01 M. Nastavek inkubiramo 24 ur pri 37 °C· Za čiščenje nato ločimo a- in nastali β-ciklodekstrin najprej preko tetrav \ kloretilenske vkljucne spojine. Po kromatografiji na premre ženem dekstranu (Sephadex LH20) dobimo 50 mg liofilizata p-nitrofenil-maltoheptaozida, ki je zelo aktiven v testu z amilazo.3.5 g α-cyclodextrin, and ml Soerensen phosphate buffer, pH 6.2; 0,01 M. Incubate the incubator for 24 hours at 37 ° C. · For purification, the α- and the resulting β-cyclodextrin are first separated via a tetravioletene inclusion compound. After chromatography on dextran excess (Sephadex LH20), 50 mg of p-nitrophenyl-maltoheptaozid lyophilisate is obtained, which is very active in the amylase assay.
PRIMER 6EXAMPLE 6
Priprava maltoheptaita g maltoheptaoze raztopimo v 5θ ml HgO, temu dodamo po obrokih 2 g NaBH^ in mešamo 75 minut pri sobni temperaturi (preskusnna-reducirani sladkor negativen). S kromatografijo na kationskem izmenjalu (Lowex 50 H+) odstranimo Na+ (pH vrednost raztopine po prehodu skozi izmenjalo 3 »5)· Raztopino po prehodu skozi izmenjalo uparimo v vakuumu in večkrat prevzamemo z metanolom/vodo (dodatek vode k raztopini proizvoda) in uparimo, da odstranimo borovo kislino kot metilester. Raztopino, ki je na koncu nevtralna, liofiliziramo.Preparation of Maltoheptaite g Maltoheptoase was dissolved in 5θ m l of HgO, 2 g of NaBH 4 was added in portions and stirred for 75 minutes at room temperature (test-reduced sugar negative). Chromatography on a cation exchanger (Lowex 50 H + ) removes Na + (pH value of the solution after passing through the exchanger 3 »5) evaporated to remove boric acid as methyl ester. The solution, which is ultimately neutral, is lyophilized.
Dobitek: 9 g (90 % teor.), brez reduktivnih sladkorjev Vsebnost (encimatsko določena) iz glukoze 86,1 % iz sorbita 89»0 % voda 8,5 %.Yield: 9 g (90% of theory), without reducing sugars Content (enzymatically determined) of glucose 86.1% of sorbitol 89 »0% water 8.5%.
- 26 PRIMER 7- 26 EXAMPLE 7
Priprava maltoheptonske kislinePreparation of maltoheptonic acid
11,5 g (0,01 Bol) maltoheptaoze in 6 g Ba-benzoata smo dali v 150 ml vode. Med mešanjem in hlajenjem smo dodali 1 ml broma in mešali še 36 ur. Po izgonu prebit nega broma z dušikom smo dodali 4 ml 4 n HpSO^ in nekaj aktivnega oglja, filtrirali in filtrat ekstrahirali s kloroformom, da smo odstranili benzojevo kislino. Vodni raztopini smo dodali 3»2 g AggCO^ in mešali (pH : nevtralno). Netopne soli smo odfiltrirali in bistro raztopino prelili preko 20 ml Amberlita JR H+. Kisli eluat smo takoj nevtralizirali z NaOH in liofilizirali.11.5 g (0.01 Bol) of maltoheptoase and 6 g of Ba-benzoate were placed in 150 ml of water. While stirring and cooling, 1 ml of bromine was added and stirred for an additional 36 hours. After the expulsion of excess bromine with nitrogen, 4 ml of 4 n HpSO 4 was added and some activated carbon was filtered and the filtrate was extracted with chloroform to remove benzoic acid. 3 2 2 g AggCOCO was added to the aqueous solution and stirred (pH: neutral). The insoluble salts were filtered off and the clear solution was poured over 20 ml of Amberlite JR H + . The acidic eluate was immediately neutralized with NaOH and lyophilized.
Dobitek: 8 g (72 % teor.)Yield: 8 g (72% of theory)
Vsebnost (encimatsko določena) iz glukoze 85 % iz glukonske kisline 80 % voda 9,3 %·Content (enzymatically determined) of glucose 85% of gluconic acid 80% of water 9,3% ·
PRIMER 8EXAMPLE 8
Dokaz α-amilaze s fenil-a-maltoheptaozidom kot substratom α-amilaza razcepi fenil-a-maltoheptaozid v fenil-a-maltotriid ali -tetraid, ki ju presnovimo z a-glukozidazo v fenol in glukozo. Sproščeni fenol pripojimo s pomočjo mono f e no 1-oksidaze oksidativno z nukleofilnim reagentom 3-metil-6-sulfonil-benztiazolon-hidrazonom-(2) (HSK) vEvidence of α-amylase with phenyl-α-maltoheptaozid as α-amylase substrate splits phenyl-α-maltoheptaozide into phenyl-α-maltotriide or -tetray, which is metabolised by α-glucosidase to phenol and glucose. The released phenol is coupled via mono-f e no 1-oxidase oxidatively with the nucleophilic reagent 3-methyl-6-sulfonyl-benzthiazolone-hydrazone- (2) (HSK) in
- 27 rdeče barvilo, čigar hitrost nastajanja je proporcionalna aktivnosti amilaze v skusku in jo lahko spremljamo fotome trično.- 27 a red dye whose rate of production is proportional to the activity of the amylase in mackerel and can be monitored photomically.
Princip testa:Test principle:
1. a) fenil-a-maltoheptaozid + Η^Ο fenil-a-Dtri-(tetra)-glukopiranozid + maltotetra-(tri)-oza1. a) phenyl-a-maltoheptaozid + Η ^ Ο phenyl-a-Dtri- (tetra) -glucopyranoside + maltotetra- (tri) -ose
b) fenil-a-D-tri-(tetra)-glukopiranozid + 3 (4) HgO > fenol + 5 (4) glukozeb) Phenyl-a-D-tri- (tetra) -glucopyranoside + 3 (4) HgO> phenol + 5 (4) glucose
e) fenol + HSK + Og / bervilo + 2 ^0e) Phenol + HSK + Og / barrel + 2 ^ 0
Merilni pogoji:Measuring conditions:
°C, merilna valovna dolžina 492 nm, 1 cm ki vete.° C, measuring wavelength 492 nm, 1 cm in veto.
ii
Sestavo reagenta prikazuje naslednja tebela.The composition of the reagent is shown in the following tables.
TABELATABLE
Reagent_Koncentracija pri testuReagent_Concentration in test
testni volumen: 2,0 mltest volume: 2.0 ml
- 28 Namesto fosfatnega puferja so se pokazali kot uporabni tudi glicinski, glicilglicinski, hepes, tris, tra in drugi puferji.- 28 Instead of phosphate buffer, glycine, glycylglycine, hepes, tris, tris, tra and other buffers have also proved useful.
PRIMER 9EXAMPLE 9
Določitev α-amilaze s p-nitrofenil-maltoheptaozidomDetermination of α-amylase by p-nitrophenyl-maltoheptaozide
Princip testa:Test principle:
p-nitrofenil-a-maltoheptaozid gramilaza> (glukoza)n + p-nitrofenil-a-(glukoza)m gc ,Sluko?I<Ia?.a» n glukoz + p-nitrofenol.p-nitrophenyl-a-maltoheptaozid gr amylase > (glucose) n + p-nitrophenyl-a- (glucose) m g c , S onion ? I < I a ?. a » n glucose + p-nitrophenol.
Po cepitvi maltoheptaozida razgradimo proizvode cepitve v glukozo in p-nitrofenol. p-nitrofenolatni anion je v alkalni raztopini obarvan rumeno in ga lahko zato direktno optično merimo.Following the cleavage of maltoheptaozid, the cleavage products are broken down into glucose and p-nitrophenol. The p-nitrophenolate anion is colored yellow in the alkaline solution and can therefore be directly optically measured.
Testni sistem:Test system:
Reakcijska zmes: 50 mM/Ι fosfatnega puferja, pH 7,4 mM/Ι natrijevega klorida do 50 U/ml a-glukozidaze oz. 10 mM/Ι p-nitrofenil-a-maltoheptaozidaReaction mixture: 50 mM / Ι phosphate buffer, pH 7.4 mM / Ι sodium chloride up to 50 U / ml α-glucosidase or. 10 mM / Ι p-nitrophenyl-α-maltoheptaozide
Testni nastavek:Test nozzle:
ml reakcijske zmesi + 50 /Ul skuska (seruma) temperatura: 50 °C val. dolžina: 405 nmml of reaction mixture + 50 / Ul maceration (serum) temperature: 50 ° C wave. length: 405 nm
- 29 Start s serumom potem, ko dosežemo merilno temperaturo (10 minut predinkubaci je).- 29 Start with serum after measuring temperature is reached (10 minutes preincubation).
PRIMER 10EXAMPLE 10
Določitev α-amilaze z maltoheptitomDetermination of α-amylase by maltoheptite
Princip testa:Test principle:
maltoheptait + HgO <x“Sgl.lazaT> maltotriit + maltotetraoza maltotriit + ^0 .^.rg^^^idaza > sorbit + maltoza sorbit + NAD+ ~DH > fruktoza + NADH + H+ maltoheptait + HgO <x “Sgl. lase T> maltotriite + maltotetraose maltotriite + ^ 0. ^. rg ^^^ idaza> sorbit + maltose sorbit + NAD + ~ DH > fructose + NADH + H +
NADH + INT + H+ diaforaza > formazan + NAD+ NADH + INT + H + diaphorase > formazan + NAD +
SDH = sorbit-dehidrogenaza.SDH = sorbit dehydrogenase.
Testni sistem:Test system:
mg/ml+ mg / ml +
- 30 Reakcijski nastavek ml Koncentracija pri testu- 30 Reaction nozzle ml Concentration in test
+ v testnem puferju+ in test buffer
Start z dodatkom skuskaj meritev se vrši pri 4-92 nm; temperatura: 25 °0.Starting with the addition of mackerel measurements is made at 4-92 nm; temperature: 25 ° 0.
PRIMER 11EXAMPLE 11
Določitev α-amilaze z maltoheptaglukonsko kislinoDetermination of α-amylase with maltoheptagluconic acid
Princip testa:Test principle:
maltoheptaglukonska kislina + HgO a ,amil&za^, maltottioglukonska kislina + maltotetraoza maltottioglukonska kislina + Hg0 glukonska kislina + maltoza glukonska kislina + ATP g1-ukoDat~kina2a> glukonske kisline-6-Ρ + ADP glukoze M.eline-6-F ♦ HADP* ribuloze-5-Ρ + NADPH + COg + H+ maltoheptagluconic acid + HgO a , am il & za ^, maltottiogluconic acid + maltotetraose maltottiogluconic acid + Hg 0 gluconic acid + maltose gluconic acid + ATP g 1 - ukoDat ~ kina2a > gluconic acids-6-M. + ADP-glucose F ♦ HADP * ribulose-5-Ρ + NADPH + COg + H +
- 51 Testni sistem:- 51 Test system:
Reakcijski nastavek ml Koncentracija pri testuReaction nozzle ml Concentration in test
II
Start z dodatkom skuska: meritev se vrši pri 340 nm ali 3θ5 nm, °c, temperatura: testni volumen:Start with the addition of mackerel: measurement is made at 340 nm or 3θ5 nm, ° c, temperature: test volume:
3,00 ml3,00 ml
Navedba o najboljšem,prijavitelju znanem? načinu za gospodarsko Izkoriščanje prijavljenega izuma p-nitrofenil-a-maltooligosaharidi z encimatsko sintezo z amilazo iz Bacillus macerans (E.C.2.4.1.19 iz Bac. mac.An indication of the best known applicant ? Utilizing the claimed invention p-nitrophenyl-α-maltooligosaccharides by enzymatic synthesis with amylase from Bacillus macerans (EC2.4.1.19 from Bac. mac.
DSM 24).DSM 24).
Amilaza iz Bacillus macerans ima poleg liidrolitskega in cikliziraega učinka tudi lastnosti transferiranja glikozila, ki jih lahko izkoristimo za sintezo oligosaharidov in derivatov oligosaharidov (Methods in Carbohydrate Chemistry II, 547). Za sintezo p-nitrofenil-oligosaharidov smo ta postopek optimirali takole:Amylase from Bacillus macerans has, in addition to its liidrolytic and cyclizing effect, glycosyl transfer properties that can be exploited for the synthesis of oligosaccharides and oligosaccharide derivatives (Methods and Carbohydrate Chemistry II, 547). For the synthesis of p-nitrophenyl oligosaccharides, this procedure was optimized as follows:
Pomešamo 680 mg amilaze iz Bacillus macerans (E.C.2.4.1.19 iz Bac. mac. DSM 24) ((liofilizat) ( odtehtek 0,46 U/mg, vsebnost proteinov v odtehtku 28,5 %, brez aktivnosti, ki cepijo p-nitrofenil-a-D-glukozid),Mix 680 mg of amylase from Bacillus macerans (EC2.4.1.19 from Bac. Mac. DSM 24) ((lyophilisate) (0.46 U / mg weight, protein content in weight 28.5%, without p-nitrophenyl cleavage activity) -aD-glucoside),
400 mg a-D-p-nitrofenilglukozida,400 mg of α-D-β-nitrophenylglucoside,
5,5 g α-ciklodekstrina, in ml Soerensenovega fosfatnega puferja, pH 6,2; 0,01 M. Nastavek inkubiramo 24 ur pri 57 Za čiščenje nato ločimo a- in nastali β-ciklodekstrin najprej preko tetrakloretilenske vključne spojine. Po kromatografiji na premre ženem dekstranu (Sephadex LH20) dobimo 50 mg liofilizata p-nitrofenil-maltobeptaozida, ki je zelo aktiven v testu z amilazo.5.5 g α-cyclodextrin, and ml Soerensen phosphate buffer, pH 6.2; 0,01 M. The incubation was incubated for 24 hours at 57. For purification, the α- and β-cyclodextrin obtained were first separated via a tetrachlorethylene inclusion compound. After chromatography on dextran excess (Sephadex LH20), 50 mg of p-nitrophenyl-maltobeptaozid lyophilisate is obtained, which is very active in the amylase assay.
Določitev »-ητη-ΐ i ft7.fi s p-nitrofenil—maltoheptaozidomDetermination of »-ητη-ΐ and ft7.fi by p-nitrophenyl-maltoheptaozide
Princip testa:Test principle:
p-nitrofenil-a-maltoheptaozid —(glukoza)n + p-nitrofenil-a-(glukoza)m a~glukozidaza» n glukoz + p-nitrofenol.p-nitrophenyl-a-maltoheptaozid - (glucose) n + p-nitrophenyl-a- (glucose) m a ~ g lucosidase » n glucose + p-nitrophenol.
Po cepitvi maltoheptaozida razgradimo proizvode cepitve v glukozo in p-nitrofenol. p-nitrofenolatni anion Je v alkalni raztopini obarvan rumeno in ga lahko zato direktno optično merimo.Following the cleavage of maltoheptaozid, the cleavage products are broken down into glucose and p-nitrophenol. p-nitrophenolate anion It is colored yellow in alkaline solution and can therefore be directly optically measured.
Testni sistem:Test system:
Reakcijska zmes: 50 mM/1 fosfatnega puferja, pH 7,4 mM/1 natrijevega klorida do 50 U/ml a-glukozidaze oz. Ί0 mM/1 p-nitrofenil-a-maltoheptaozidaReaction mixture: 50 mM / l phosphate buffer, pH 7.4 mM / l sodium chloride to 50 U / ml α-glucosidase or. M0 mM / 1 p-nitrophenyl-α-maltoheptaozide
Testni nastavek:Test nozzle:
ml reakcijske zmesi + 50 /Ul skuska (seruma} temperatura: 50 °C val. dolžina: 405 nmml of reaction mixture + 50 / Ul maceration (serum} temperature: 50 ° C wavelength: 405 nm
Start s serumom potem, ko dosežemo merilno temperaturo (10 minut predinkubacije).Start with serum after reaching measuring temperature (10 minutes preincubation).
Claims (11)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2741192A DE2741192C2 (en) | 1977-09-13 | 1977-09-13 | Method for the determination of alpha-amylase |
DE19772755803 DE2755803A1 (en) | 1977-12-14 | 1977-12-14 | METHOD AND REAGENT FOR DETERMINING ALPHA-AMYLASE |
YU2162/78A YU44180B (en) | 1977-09-13 | 1978-09-12 | Process for determining alpha-amilase |
Publications (1)
Publication Number | Publication Date |
---|---|
SI7812162A8 true SI7812162A8 (en) | 1997-12-31 |
Family
ID=27187308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI7812162A SI7812162A8 (en) | 1977-09-13 | 1978-09-12 | Process for determining alpha-amilase |
Country Status (2)
Country | Link |
---|---|
HR (1) | HRP940727B1 (en) |
SI (1) | SI7812162A8 (en) |
-
1978
- 1978-09-12 SI SI7812162A patent/SI7812162A8/en unknown
-
1994
- 1994-10-21 HR HRP-2162/78A patent/HRP940727B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HRP940727B1 (en) | 1996-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4544631A (en) | Process and reagent for the determination of α-amylase | |
Hass et al. | The Mechanism of Glucose-6-phosphatase1 | |
US4649108A (en) | Alpha amylase assay | |
US6764829B2 (en) | Nucleoside hydrolase and nucleoside phosphorylase detection kits, dipsticks and substrates | |
EP0263435B1 (en) | An aromatic substituted glycoside | |
US4818692A (en) | Method and reagent compositions for determining alpha amylase using a blocked and labeled substrate | |
US4668622A (en) | Phenolsulphonphthaleinyl-β-D-galactosides and diagnostic agents containing them | |
JPH027589B2 (en) | ||
US5077200A (en) | Azo dye chromogenic substrates | |
SI7812162A8 (en) | Process for determining alpha-amilase | |
US4794078A (en) | Alpha amylase assay | |
CS236751B2 (en) | Processing of substrates for determining of alpha-amylase | |
US5158872A (en) | Aromatic substituted glycoside | |
JPH0565292A (en) | Crystalline thionicotinamide-adenine dinucleotide phosphate potassium salt and process for producing the same | |
Shibaoka et al. | Quantitative Determination of Anomeric Forms of Sugar Produced by Amylases: V. Anomeric Forms of Maltose Produced in the Hydrolytic Reaction of Substituted Phenyl α-Maltosides Catalyzed by Saccharifying α-Amylase from B. subtilis | |
JPS63214193A (en) | Production of 6-glucosylmaltooligosaccharide derivative and measurement of alpha-amylase activity using said derivative | |
IE47954B1 (en) | Process for the preparation of maltoheptaoside derivatives | |
JPH03200801A (en) | Anhydromaltooligoside derivative, reagent for assaying alpha-amylase activity containing the same as effective component, and assay of alpha-amylase activity | |
JPH0532687A (en) | Alkoxymethylidene maltooligosaccharide derivative, reagent for measuring α-amylase activity containing the same, and method for measuring α-amylase activity using the same | |
JPH07126281A (en) | Production of non-reducing end modified oligosaccharide derivative | |
JPH08291A (en) | Determination of alpha-amylase activity and reagent therefor | |
JPH09289899A (en) | Substrate for measuring alpha-amylase activity, measuring reagent and measurement |